Eisai Chemical Development is categorized under Commercial Medical Research in Andover, MA .
Eisai Chemical Development was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 4539981 by the NAICS.
If you are seeking more information, feel free to contact Paul Drahnak at the company’s single location by writing to 100 Federal St, Andover, Massachusetts MA 01810 or by phoning (978) 946-7000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Eisai Chemical Development |
| Contact Person: | Paul Drahnak |
| Address: | 100 Federal St, Andover, Massachusetts 01810 |
| Phone Number: | (978) 946-7000 |
| Website Address: | eisai.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 4539981 |
| Share This Business: |
Eisai Chemical Development was started in 0 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 4539981. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Paul Drahnak for inquiries that concern Eisai Chemical Development by calling the company number (978) 946-7000, as your correspondence is most welcome. Additionally, the physical location of the single location of Eisai Chemical Development can be found at the coordinates 42.68772,-71.20112 as well as the street address 100 Federal St in Andover, Massachusetts 01810.
For its online presence, you may visit Eisai Chemical Development’s website at eisai.com and engage with its social media outlets through on Twitter and on Facebook.